Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry PerspectiveAdarsh Kumar, Pradeep Kumar, Ankit Kumar Singh et al.|Pharmaceuticals|2023Cited by 317
Concept of Hybrid Drugs and Recent Advancements in Anticancer HybridsAnkit Kumar Singh, Pradeep Kumar, Adarsh Kumar et al.|Pharmaceuticals|2022Cited by 190
The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-reviewChengyuan Liang, Suresh Thareja, Minyi Jia et al.|European Journal of Medicinal Chemistry|2018Cited by 168
Strategies to target the Hedgehog signaling pathway for cancer therapyMinhang Xin, Binghe Wang, Suresh Thareja et al.|Medicinal Research Reviews|2018Cited by 108
Gaussian field-based 3D-QSAR and molecular simulation studies to design potent pyrimidine–sulfonamide hybrids as selective BRAF<sup>V600E</sup>inhibitorsAnkit Kumar Singh, Pradeep Kumar, Mariusz Jaremko et al.|RSC Advances|2022Cited by 34